» Articles » PMID: 27542389

Role of Epigenetics in Modulation of Immune Response at the Junction of Host-pathogen Interaction and Danger Molecule Signaling

Overview
Journal Pathog Dis
Date 2016 Aug 21
PMID 27542389
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Epigenetic mechanisms have rapidly and controversially emerged as silent modulators of host defenses that can lead to a more prominent immune response and shape the course of inflammation in the host. Thus, the epigenetics can both drive the production of specific inflammatory mediators and control the magnitude of the host response. The epigenetic actions that are predominantly shown to modulate the host defense against microbial pathogens are DNA methylation, histone modification and the activity of non-coding RNAs. There is also growing evidence that opportunistic chronic pathogens, such as Porphyromonas gingivalis, as a microbial host subversion strategy, can epigenetically interfere with the host DNA machinery for successful colonization. Similarly, the novel involvement of small molecule 'danger signals', which are released by stressed or infected cells, at the center of host-pathogen interplay and epigenetics is developing. In this review, we systematically examine the latest knowledge within the field of epigenetics in the context of host-derived danger molecule and purinergic signaling, with a particular focus on host microbial defenses and infection-driven chronic inflammation.

Citing Articles

Immune Homeostasis: A Novel Example of Teamwork.

Kumar V, Stewart 4th J Methods Mol Biol. 2024; 2782:1-24.

PMID: 38622389 DOI: 10.1007/978-1-0716-3754-8_1.


A Palearctic view of a bat fungal disease.

Whiting-Fawcett F, Blomberg A, Troitsky T, Meierhofer M, Field K, Puechmaille S Conserv Biol. 2024; 39(1):e14265.

PMID: 38616727 PMC: 11780211. DOI: 10.1111/cobi.14265.


Epigenetic changes to gene pathways linked to male fertility in ex situ black-footed ferrets.

Tennenbaum S, Bortner R, Lynch C, Santymire R, Crosier A, Santiestevan J Evol Appl. 2024; 17(1):e13634.

PMID: 38283602 PMC: 10818088. DOI: 10.1111/eva.13634.


Modeling and Remodeling the Cell: How Digital Twins and HCMV Can Elucidate the Complex Interactions of Viral Latency, Epigenetic Regulation, and Immune Responses.

McMahon-Cole H, Johnson A, Aghamiri S, Helikar T, Crawford L Curr Clin Microbiol Rep. 2023; 10(3):141-151.

PMID: 37901689 PMC: 10601359. DOI: 10.1007/s40588-023-00201-w.


The mechanisms and factors that induce trained immunity in arthropods and mollusks.

Zhao M, Lin Z, Zheng Z, Yao D, Yang S, Zhao Y Front Immunol. 2023; 14:1241934.

PMID: 37744346 PMC: 10513178. DOI: 10.3389/fimmu.2023.1241934.


References
1.
Adcock I . HDAC inhibitors as anti-inflammatory agents. Br J Pharmacol. 2007; 150(7):829-31. PMC: 2013887. DOI: 10.1038/sj.bjp.0707166. View

2.
Crisan T, Netea M, Joosten L . Innate immune memory: Implications for host responses to damage-associated molecular patterns. Eur J Immunol. 2016; 46(4):817-28. DOI: 10.1002/eji.201545497. View

3.
Tan J, Cang S, Ma Y, Petrillo R, Liu D . Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents. J Hematol Oncol. 2010; 3:5. PMC: 2827364. DOI: 10.1186/1756-8722-3-5. View

4.
Carson 4th W, Cavassani K, Ito T, Schaller M, Ishii M, Dou Y . Impaired CD4+ T-cell proliferation and effector function correlates with repressive histone methylation events in a mouse model of severe sepsis. Eur J Immunol. 2010; 40(4):998-1010. PMC: 3040412. DOI: 10.1002/eji.200939739. View

5.
Leoni F, Fossati G, Lewis E, Lee J, Porro G, Pagani P . The histone deacetylase inhibitor ITF2357 reduces production of pro-inflammatory cytokines in vitro and systemic inflammation in vivo. Mol Med. 2006; 11(1-12):1-15. PMC: 1449516. DOI: 10.2119/2006-00005.Dinarello. View